Progression patterns and site‐specific responses in advanced gastric cancer patients treated with nivolumab
Abstract Background While the efficacy of immune checkpoint inhibitors (ICIs) reportedly varies among metastatic sites and progression patterns (classified as systemic progression [SP] or mixed progression [MP]), the clinical efficacy of ICIs against gastric cancer remains unclear. The response to n...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wiley
2023-04-01
|
| Серии: | Cancer Medicine |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1002/cam4.5689 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|